Entering text into the input field will update the search result below

Interventional Cardiology Devices Market To Reach US$11.2 Billion By 2022 Due To Increasing Incidence Of Coronary Artery Diseases

Nov. 25, 2015 8:48 AM ETTMR
jessbruce profile picture
jessbruce's Blog
26 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

A new report has been published by Transparency Market Research, titled "Interventional Cardiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022". TMR, a market intelligence company based in the U.S., states that the global interventional cardiology devices market was estimated at US$8.7 billion in 2013, is expanding at a CAGR of 2.9% from 2014 to 2022, and is predicted to reach US$11.2 billion in 2022.As per the TMR report, it was about 50 years ago that coronary artery bypass surgery (CABG) was developed for treating multi-vessel coronary artery disease (CAD) and complex ischemia. Interventional cardiology is defined as a minimally invasive catheter-based technology and minimally invasive surgeries have several benefits such as reduced cost, shorter hospital stay, minimal incision, shorter recovery time, and less post-surgical complications. These benefits are helping growth of the interventional cardiology devices market.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=853

According to this TMR report, on the basis of device type, the global market for interventional cardiology devices market is segmented into: catheters, stents, percutaneous transluminal coronary angioplasty (PTCA) guide wires, percutaneous transluminal coronary angioplasty (PTCA) balloons, and others.Amongst these, the biggest share was held by the stents segment. Stents are further bifurcated into drug eluting stents, bare metal stents, and bioabsorbable vascular stents. Amongst these, in 2014, the drug eluting stents held the biggest market share in the global market for interventional cardiology devices and is set to govern the market through the forecasting horizon.The TMR report states that the increasing incidence of coronary artery diseases and increasing geriatric population are amongst the major reasons stimulating the development of the global interventional cardiology market. Rising incidence of factors such as obesity, smoking, and dietary irregularities are responsible for the rising prevalence of cardiac artery diseases.

Nonetheless, CABG procedures are experiencing a decline because of the evolution of interventional techniques, as per the studies directed by the NCBI. In Europe, CAD is responsible for about 1.9 million deaths every year, of which more than 400,000 are premature deaths. Thus, the disease is a key cause of premature deaths in Europe. Therefore, the increased occurrence of coronary artery diseases will rise demand for percutaneous coronary interventions, which would boost the development of the market for interventional cardiology devices.As per this TMR research report, this market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and North Africa, and Rest of the World (RoW). North America led the market for global interventional cardiology devices, trailed by Europe, due to the consistent implementation of drug eluting stents, which are premium priced.

Asia Pacific stood as the third biggest market for interventional cardiology devices. This region is predicted to record the highest CAGR through the forecasting horizon. Developing healthcare infrastructure and rising occurrence of coronary artery disease will stimulate the development of this market in the region.Key players in the interventional cardiology devices market include Cordis Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, St. Jude Medical, Inc., Medtronic, plc, Terumo Medical Corporation, and Smiths Medical.

Key Segments of the Interventional Cardiology Devices Market

Global Interventional Cardiology Devices Market, by Device Type
Stents

  • Bare Metal Stents
  • Drug-Eluting Stents
  • Bio-absorbable Stents

Catheters

  • Angiography Catheters
  • Guiding Catheters
  • Pulmonary Artery Catheters
  • Intravascular ultrasound (IVUS) Catheters

PTCA Balloons

  • Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug-eluting Balloons

Imaging Systems

  • IVUS (intravascular ultrasound)
  • FFR (Fractional Flow Reserve)
  • OCT (Optical Coherence Tomography)

Percutaneous Transluminal Coronary Angioplasty Guidewires
Others

Global Interventional Cardiology Devices Market, by Geography

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Rest of Asia Pacific

Latin America (LATAM)

  • Brazil
  • Mexico
  • Rest of LATAM

Middle East North Africa (MENA)

  • Saudi Arabia
  • United Arab Emirates
  • Rest of MENA

Rest of the World (RoW)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You